Stock Earnings

Question 1

Starpharma Holdings Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Starpharma Holdings Ltd'in toplam varlıkları $25 olup, net loss $-9'dir.

Question 2

SPHRY'ün temel finansal oranları nelerdir?

Accepted Answer

Starpharma Holdings Ltd'in cari oranı 4.16, net kâr marjı -180, hisse başına satış $0.01'dir.

Question 3

Starpharma Holdings Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Starpharma Holdings Ltd largest revenue segment is Dendrimers, at a revenue of 8,289,000 in the most earnings release.For geography, Australia is the primary market for Starpharma Holdings Ltd, at a revenue of 8,289,000.

Question 4

Starpharma Holdings Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Starpharma Holdings Ltd'in net loss $-9'dir.

Question 5

Starpharma Holdings Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Starpharma Holdings Ltd'in yükümlülüğü 6'dir.

Question 6

Starpharma Holdings Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Starpharma Holdings Ltd'in toplam tedavüldeki hisse sayısı 418.22'dir.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	5	5	9	4	4	2
Revenue Growth (YoY)	-44%	-44%	125%	0%	100%	-71%
Cost of Revenue	1	1	0	1	2	0
Gross Profit	4	4	9	3	2	1
Selling, General & Admin	6	6	7	7	6	7
Research & Development	12	12	15	18	18	22
Operating Expenses	14	14	17	18	18	22
Other Non Operating Income (Expenses)	--	--	0	0	0	1
Pretax Income	-9	-9	-8	-15	-16	-19
Income Tax Expense	0	0	0	0	0	0
Net Income	-9	-9	-8	-15	-16	-19
Net Income Growth	13%	13%	-47%	-6%	-16%	36%
Shares Outstanding (Diluted)	418.15	417.17	411.43	409.03	406.9	396.87
Shares Change (YoY)	1%	1%	1%	1%	3%	7%
EPS (Diluted)	-0.02	-0.02	-0.01	-0.03	-0.03	-0.04
EPS Growth	21%	21%	-48%	-4%	-20%	26%
Free Cash Flow	-6	-6	-7	-14	-13	-15
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.03	-0.03	-0.03
Gross Margin	80%	80%	100%	75%	50%	50%
Operating Margin	-180%	-180%	-88.88%	-375%	-400%	-1,050%
Profit Margin	-180%	-180%	-88.88%	-375%	-400%	-950%
Free Cash Flow Margin	-120%	-120%	-77.77%	-350%	-325%	-750%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-9	-9	-8	-15	-16	-21
EBIT Margin	-180%	-180%	-88.88%	-375%	-400%	-1,050%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Starpharma Holdings Ltd (SPHRY) Price

SPHRY Stock Price Chart

SPHRY Income

Follow-Up Questions